Genscript Biotech Corporation (GNNSF)
USD 1.25
(0.0%)
USD 1.25
(0.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -283.61 Million | -120.29 Million | -136.79 Million | -151.09 Million | -29.95 Million | 295.41 Million |
| Net Income | -95.7 Million | -431.69 Million | -496.37 Million | -281.9 Million | -113.69 Million | 22.7 Million |
| Depreciation & Amortization | 74.11 Million | 64.24 Million | 47.77 Million | 32.89 Million | 20.64 Million | 12.93 Million |
| Deferred income taxes | - | 13.27 Million | 12.02 Million | 15.92 Million | -8.23 Million | 2.36 Million |
| Stock-based compensation | 60.59 Million | 65.15 Million | 39.69 Million | 17.63 Million | 10.78 Million | 8.85 Million |
| Change in working capital | -88.46 Million | 169.75 Million | 121.67 Million | -16.48 Million | 68.11 Million | 258.51 Million |
| Other non-cash items | 132.97 Million | -1.03 Million | 138.41 Million | 80.82 Million | -7.56 Million | -9.95 Million |
| Investing Cash Flow | -358.87 Million | -443.29 Million | -212.54 Million | -100.16 Million | -208.63 Million | -181.66 Million |
| Investments in PPE | -158.08 Million | -203.57 Million | -137.39 Million | -127.74 Million | -118.53 Million | -79.6 Million |
| Acquisitions | 177.41 Thousand | -914 Thousand | -3.76 Million | -2.06 Million | -9.8 Million | -29.48 Million |
| Investment purchases | -5.76 Billion | -409.62 Million | -322.56 Million | -430.72 Million | -1.33 Billion | -74.99 Million |
| Sales/Maturities of investments | 5.66 Billion | 187.69 Million | 243.98 Million | 462.98 Million | 1.23 Billion | 830 Thousand |
| Other Investing Activities | -99.01 Million | -16.88 Million | 7.19 Million | -2.61 Million | 19.88 Million | 1.59 Million |
| Financing Cash Flow | 1.07 Billion | 419.31 Million | 902.14 Million | 624.2 Million | -2.77 Million | 257.27 Million |
| Debt repayment | -49.89 Million | -463 Thousand | -71.21 Million | -28.72 Million | -18.99 Million | -10.51 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | -9.46 Million | -7.77 Million | -11.47 Million |
| Common Stock Issuance | 1.03 Billion | 423.3 Million | 951.22 Million | 459.56 Million | 3.73 Million | 253.97 Million |
| Other Financing Activities | -2.23 Million | -3.52 Million | 22.12 Million | 405.27 Million | 46.09 Million | 14.77 Million |
| Accounts receivables | -117.26 Million | 38.15 Million | 1.56 Million | -69.92 Million | -14.11 Million | 212.03 Million |
| Accounts payables | -37.11 Million | 25.63 Million | 8.04 Million | 5.42 Million | 16.01 Million | 2.96 Million |
| Inventory | -3.93 Million | -14.23 Million | -15.13 Million | -14.96 Million | -8.41 Million | -5.4 Million |
| Other working capital | 69.84 Million | 120.19 Million | 127.2 Million | 62.98 Million | 74.63 Million | 263.91 Million |
| Cash at beginning of period | 1.05 Billion | 1.18 Billion | 629.05 Million | 252.39 Million | 494.55 Million | 123.85 Million |
| Cash at end of period | 1.47 Billion | 1.02 Billion | 1.18 Billion | 629.05 Million | 252.39 Million | 494.55 Million |
| Capital Expenditure | -158.08 Million | -203.57 Million | -137.39 Million | -127.74 Million | -118.53 Million | -79.6 Million |
| Effect of forex changes on cash | -1.21 Million | -12.7 Million | -890 Thousand | 3.71 Million | -795 Thousand | -318 Thousand |
| Net cash flow / Change in cash | 428.8 Million | -156.97 Million | 551.91 Million | 376.66 Million | -242.16 Million | 370.7 Million |
| Free Cash Flow | -441.7 Million | -323.86 Million | -274.18 Million | -278.84 Million | -148.49 Million | 215.8 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -87.55 Million | -87.55 Million | -1.89 Million | -95.7 Million | -948 Thousand | -93.57 Million |
| Depreciation & Amortization | 20.14 Million | 20.14 Million | 38.52 Million | 74.11 Million | 18.16 Million | 35.52 Million |
| Deferred income taxes | - | - | -117.51 Million | - | - | -135.76 Million |
| Stock-based compensation | 26.67 Million | 26.67 Million | 10.86 Million | 60.59 Million | 10.86 Million | 19.42 Million |
| Change in working capital | 46.58 Million | 46.58 Million | -14.42 Million | -88.46 Million | -47.25 Million | -73.66 Million |
| Other non-cash items | 34.07 Million | 34.07 Million | 71.58 Million | 132.97 Million | -30.7 Million | 61.39 Million |
| Investing Cash Flow | -566.52 Million | -566.52 Million | 99.04 Million | -358.87 Million | 48.4 Million | -455.83 Million |
| Investments in PPE | -67.01 Million | -67.01 Million | -76.49 Million | -158.08 Million | -86.12 Million | -81.09 Million |
| Acquisitions | 458.49 Thousand | - | 177.19 Thousand | 177.41 Thousand | - | -1.00 |
| Investment purchases | -2.72 Billion | - | -4.74 Billion | -5.76 Billion | - | -1.01 Billion |
| Sales/Maturities of investments | 1.72 Billion | - | 4.96 Billion | 5.66 Billion | - | 695.52 Million |
| Other Investing Activities | -499.51 Million | -499.51 Million | -45.68 Million | -99.01 Million | 134.53 Million | -53.01 Million |
| Financing Cash Flow | 2.78 Million | 2.78 Million | 47.99 Million | 1.07 Billion | 24.12 Million | 1.02 Billion |
| Debt repayment | -18.05 Million | - | -46.97 Million | -49.89 Million | - | -2.85 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 4.39 Million | - | 5.2 Million | 1.03 Billion | - | 1.02 Billion |
| Other Financing Activities | 2.78 Million | 2.78 Million | 24.12 Million | -2.23 Million | 24.12 Million | 510 Million |
| Accounts receivables | 41.64 Million | 41.64 Million | -86.39 Million | -117.26 Million | -43.18 Million | -30.61 Million |
| Accounts payables | 17.84 Million | - | -21.58 Million | -37.11 Million | - | -15.42 Million |
| Inventory | -2.45 Million | -2.45 Million | -4.68 Million | -3.93 Million | -2.33 Million | 747.98 Thousand |
| Other working capital | 7.4 Million | 7.4 Million | 98.23 Million | 69.84 Million | -1.72 Million | -28.37 Million |
| Cash at beginning of period | 1.47 Billion | - | 1.42 Billion | 1.05 Billion | - | 1.05 Billion |
| Cash at end of period | 408.76 Million | -523.55 Million | 1.47 Billion | 1.47 Billion | 24.53 Million | 1.42 Billion |
| Capital Expenditure | -67.01 Million | -67.01 Million | -76.49 Million | -158.08 Million | -86.12 Million | -81.09 Million |
| Effect of forex changes on cash | 264 Thousand | 264 Thousand | 1.87 Million | -1.21 Million | 1.87 Million | -2.48 Million |
| Net cash flow / Change in cash | -1.07 Billion | -523.55 Million | 56.66 Million | 428.8 Million | 24.53 Million | 372.14 Million |
| Free Cash Flow | -27.08 Million | -27.08 Million | -172.42 Million | -441.7 Million | -135.99 Million | -267.76 Million |
POH1
HSHIF
GATO
PINFRA
RF-PB
0251